FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
作者信息
Grothey Axel, Sargent Daniel J
机构信息
Mayo Clinic College of Medicine, Department of Medical Oncology, Rochester, MN, USA.
出版信息
J Clin Oncol. 2005 May 20;23(15):3311-3. doi: 10.1200/JCO.2005.11.691.
PMID:15908645
Abstract
摘要
Zotero 插件